Sequence occurrence and structural uniqueness of a G-quadruplex in the human c-kit promoter by Todd, Alan K. et al.
Published online 24 August 2007 Nucleic Acids Research, 2007, Vol. 35, No. 17 5799–5808
doi:10.1093/nar/gkm609
Sequence occurrence and structural uniqueness
of a G-quadruplex in the human c-kit promoter
Alan K. Todd, Shozeb M. Haider, Gary N. Parkinson and Stephen Neidle*
Cancer Research UK Biomolecular Structure Group, The School of Pharmacy, University of London,
29-39 Brunswick Square, London WC1N 1AX, UK
Received May 18, 2007; Revised July 24, 2007; Accepted July 26, 2007
ABSTRACT
The 22-nt c-kit87 promoter sequence is unique
within the human genome. Its fold and tertiary
structure have recently been determined by NMR
methods [Phan,A.T., Kuryavyi,V., Burge,S., Neidle,S.
and Patel,D.J. (2007) Structure of an unprecedented
G-quadruplex scaffold in the c-kit promoter. J. Am.
Chem. Soc., 129, 4386–4392], and does not have
precedent among known DNA quadruplexes.
We show here using bioinformatics and molecular
dynamics simulations methods that (i) none of the
closely related sequences (encompassing all
nucleotides not involved in the maintenance of
structural integrity) occur immediately upstream
(<100nt) of a transcription start site, and (ii) that
all of these sequences correspond to the same
stable tertiary structure. It is concluded that the
c-kit87 tertiary structure may also be formed in
a very small number of other loci in the human
genome, but the likelihood of these playing a
significant role in the expression of particular
genes is very low. The c-kit87 quadruplex thus fulfils
a fundamental criterion of a ‘good’ drug target, in
that it possesses distinctive three-dimensional
structural features that are only present in at most
a handful of other genes.
INTRODUCTION
The proto-oncogene c-kit encodes for a 145–160kDa
tyrosine kinase receptor, which is especially expressed in
mast cells, melanocytes and hematopoetic stem cells (1,2).
The tyrosine kinase domain of c-kit has become an
important molecular target for the treatment of gastro-
intestinal stromal tumors (GIST), and the small molecule
kinase inhibitor Gleevec has become the most signiﬁcant
therapy for GIST, where it has made a major diﬀerence to
survival rates (3–6). Over-expression and/or mutation of
c-kit may also play a signiﬁcant role in several other
cancers, including some leukaemias (7) and testicular
cancers (8). However, resistance to Gleevec occurs as a
result of deactivating mutations in the kinase active site
(6,9–11). These diminish binding and rapidly reduce the
clinical eﬀectiveness of the drug. Several 2nd-generation
c-kit kinase inhibitors are currently being developed to
overcome this resistance (12–15), although it is possible
that they in turn may produce new patterns of resistance
mutations in the kinase active site.
Selective gene regulation at the transcriptional level is a
potential alternative to targeting a protein, the product of
gene expression. One way in which this can be achieved
is by the induction of higher-order G-quadruplex DNA
structures (16) in a G-rich region such as a promoter
sequence (17–20) by a small-molecule ligand. This
has been demonstrated for the c-myc oncogene at the
nuclease hypersensitivity element (NHE) III1 that is
responsible for up to 90% of c-myc transcription (21,22).
G-quadruplexes, which may have transient stability by
themselves when embedded within the double-stranded
DNA of a eukaryotic gene, may thus be stabilized further
by a small-molecule ligand. The structure and topology
of two c-myc DNA quadruplexes have been determined
by NMR spectroscopy (23,24), as well as that of a ligand
(TMPyP4) complex (25). These are structurally complex
parallel-stranded quadruplexes, with several strand-
reversal loops and base-pair platforms.
Two discrete G-rich quadruplex-forming sequences
have been identiﬁed (26,27) in the human c-kit core
promoter region (28–30). These are within the nuclease
hypersensitive region of the promoter, suggesting that they
are not involved in a chromatin complex. Biophysical
and 1-D NMR studies have shown that these individual
sequences can both form G-quadruplex structures (26,27).
One sequence, d(AGGGAGGGCGCTGGGAGGA
GGG), which occurs 87-nt upstream of the transcription
start site, forms a single G-quadruplex species in solution
(26). The occurrence of four tracts of three consecutive
guanines (underlined), separated by linkers of either one
or four residues initially suggested that the sequence forms
a G-quadruplex structure with these G-tracts forming the
G-tetrad core, and the linker sequences forming loops,
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intramolecular telomeric quadruplex (31). However, this
proposed model was unable to explain the dramatic
quadruplex destabilizing eﬀect caused by mutations in the
linker sequences (26).
The NMR-based solution structure of the
G-quadruplex formed by this precise sequence in K
+
solution has now been determined (32), and shows that
c-kit87 has an unprecedented G-quadruplex folding
topology that involves 18 of the 22nt in tertiary
interactions (Figure 1), and providing rationales for the
mutant data (26,32). These four non-essential nucleotides
are in bold in the above sequence. One of the ‘loop’
guanine bases is directly involved in G-tetrad core
formation, contrary to expectations and despite the
presence of four three-guanine tracts. There are also
four loops; two single-nucleotide double-chain-reversal
loops, a two-residue loop, and a ﬁve-residue d(AGGAG)
stem-loop. The net result is a tertiary quadruplex structure
with complex features absent in simpler quadruplexes
such as the human telomeric parallel and antiparallel
arrangements. In particular, the presence of two well-
deﬁned clefts in the structure that are deﬁned by the
stem-loop and the two-residue loop strongly suggest that
the c-kit87 quadruplex could be a target for the design of
selective small molecules that would serve to stabilize the
structure within the context of the core promoter
sequence, and thus down-regulate c-kit expression. The
structure allows for straightforward continuation of
a DNA sequence in both 50 and 30 directions, suggesting
that it could be formed within the promoter region
without undue steric constraint.
The potential of c-kit87 as a therapeutic target raises the
question of the degree of its sequence and structural
uniqueness. This issue is addressed here using a combined
bioinformatics, circular dichroism (CD) and molecular
dynamics simulation approach.
METHODS
Informatics
The Ensembl human genome core database (33) version
38 (NCBI build 36) was searched for sequences of the
patterns:
AGGGwGGGwGwTGGGAGGAGGG
AGGGwGGGwGwTGGGAGwAGGG
TGGGwGGGwGwAGGGAGwAGGG
CGGGwGGGwGwGGGGAGwAGGG
GGGGwGGGwGwCGGGAGwAGGG
where w represents any base, at positions 5, 9, 11 and 18
that are not involved in tertiary interactions in the
structure.
The search software was that developed for earlier
quadruplex searches (17). The positions of each hit within
the chromosome and its relation to the surrounding genes,
or the gene within which it occurred, was recorded and
compiled into a mySQL database. This database was then
queried so that the results could be ordered and grouped
as desired. Where sequences occurred upstream relative
to the transcription direction of a gene, the distance
between the gene and the transcription start site was
retrieved and in the case where one of the hit sequences
occurred within a gene, it was noted in which intron,
exon or untranslated region the sequence occurred.
Searches for the mutated c-kit sequences which were
previously examined (26) and shown not to form
quadruplex structures, were also carried out, in the same
way as described above. These sequences are:
d(AGGGAGGGAGGAGGGAGGAGGG)
d(AGGGAGGGCGCTGGGCGCTGGG)
d(AGGGAGGGCGCTGGGCGGCGGG)
Additional variations of these mutated sequences were
also investigated. The human genome was searched for
the following sequences with systematic variations at the
5, 9, 11 and 18 positions:
d(AGGGwGGGwGwAGGGAGwAGGG) sequences 1m
d(AGGGwGGGwGwTGGGCGwTGGG) sequences 2m
d(AGGGwGGGwGwTGGGCGwCGGG) sequences 3m
The c-kit upstream regions from various diﬀerent
species were obtained from the Ensembl web site
www.ensembl.org (using Ensembl release 43). Upstream
regions for the orthologues to the human c-kit sequence
were found for macaque, rat, mouse, cow, opossum
chicken and zebraﬁsh. A multiple sequence alignment was
carried out on these sequences using the CLUSTAL
software package (34).
Figure 1. One of the NMR structures of the c-kit87 quadruplex, taken
from the PDB entry 2O3M, and drawn with the UCSF Chimera
package from the Resource for Biocomputing, Visualization,
and Informatics at the University of California, San Francisco
(Pettersen,E.F., Goddard,T.D., Huang,C.C., Couch,G.S.,
Greenblatt,D.M., Meng,E.C., and Ferrin,T.E. UCSF chimera - a
visualization system for exploratory research and analysis. (2004).
J. Comput. Chem., 25, 1605–1612). Nucleotides A5, C9 and C11 are
coloured red, and G18 is in green.
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The c-kit87 and the ten mutant sequences were synthesized
and hplc puriﬁed (Eurogentec), and were then used in this
study:
[A5G] d(AGGGGGGGCGCTGGGAGGAGGG)
[A5C] d(AGGGCGGGCGCTGGGAGGAGGG)
[A5T] d(AGGGTGGGCGCTGGGAGGAGGG)
[C9G] d(AGGGAGGGGGCTGGGAGGAGGG)
[C9A] d(AGGGAGGGAGCTGGGAGGAGGG)
[C9T] d(AGGGAGGGTGCTGGGAGGAGGG)
[C11G] d(AGGGAGGGCGGTGGGAGGAGGG)
[C11A] d(AGGGAGGGCGATGGGAGGAGGG)
[C11T] d(AGGGAGGGCGTTGGGAGGAGGG)
[G18T] d(AGGGAGGGCGCTGGGAGTAGGG)
c-kit87 native d(AGGGAGGGCGCTGGGAGGAGGG)
CD spectra for them were acquired on a Chirascan
spectrometer (Applied Photophysics Ltd) at King’s
College London. All samples were prepared at 100mM
in 50mM potassium chloride and heated to 958C and
slowly annealed overnight to room temperature. The
samples were further diluted, with buﬀer to 1 optical
density unit prior to data collection. UV absorbance and
CD spectra were measured between 360 and 200nm in a
10mm path-length cell. Spectra were recorded with a
0.5nm step size, a 1.5s time-per-point and a spectral
bandwidth of 1nm. All spectra were acquired at room
temperature and buﬀer baseline corrected. The concentra-
tions of the above oligonucleotides were determined
by using the absorbance value at 260nm and the
Beer–Lambert law.
Molecular dynamics simulations
One of the experimental c-kit87 NMR structures (PDB
accession code 2O3M) was arbitrarily chosen and used
as a starting point for all calculations. Mutants occurring
with high frequency were identiﬁed using the bioinfor-
matics techniques outlined above. Structural modiﬁca-
tions were made to the native c-kit87 model to generate
3D models from these mutant sequences, changing only
the base; backbone conformations were not altered at all.
This was carried out using the Insight suite of programs
(www.accelrys.com). In all, ten mutants were constructed
and are listed in Table 1.
Molecular dynamics simulations were carried out using
the ﬀ99 forceﬁeld in the AMBER v9.0 package (36). Each
system was equilibrated with explicit solvent molecules
(TIP3P) using 1000 steps of minimization and 20ps of
molecular dynamics at 300K. The entire systems were
kept constrained, while allowing the ions and the solvent
molecules to equilibrate. The systems were then subjected
to a series of dynamics calculations in which the con-
straints were gradually relaxed, until no constraints at all
were applied. The ﬁnal production run was performed
without any restrain on the complex for 10ns and
co-ordinates were saved after every 10ps for analysis of
their trajectories. The simulation protocols were consistent
for all of the systems. Periodic boundary conditions were
applied, with the particle-mesh Ewald (PME) method (37)
used to treat the long-range electrostatic interactions.
The solute was ﬁrst solvated in a TIP3P water box (38),
the boundaries of which were at least at a distance of 10A ˚
from any solute atoms. Additional positively charged K
+
counter-ions were included in the system to neutralize the
charge on the DNA backbone. The counter-ions were
automatically placed by the LEAP program throughout
the water box at grid points of negative Coulombic
potential. The ﬁnal system had net zero charge.
All calculations were carried out using the SANDER
module, trajectories were analysed using the PTRAJ
module from the AMBER9.0 suite and viewed using
the VMD program (39).
RESULTS
Informatics
The c-kit87 experimental structure contains three looped-
out bases (A5, C9 and C11), which visual inspection
(Figure 1) shows do not play a role in maintaining
structural integrity, since they do not interact directly with
any part of the folded structure. Other notable features of
the structure are (i) a Watson–Crick base pair between A1
and T12 and (ii) the AGGAG stem loop, which contains
two A...G base pairs. The middle guanine, G18 in this
loop sequence, stacks on the end of the loop and is not
involved in any hydrogen bonding with other residues.
Changing A5 and C9 to thymines has been found (32) to
produce a structure with the same topology as the native;
changing C11 to thymine produces a mixture of structures
with a similar topology but where one structure contains
an A1–T11 base pair and the other an A1–T12 base pair,
as in the native structure. Modiﬁcation of G18 to T18 also
maintains the topology.
We have therefore searched through the human genome
for all possible sequence variations at these four positions,
in order to assess their implications for the uniqueness of
the sequence and the structure. All variations have been
examined, at positions 5, 9, 11 and 18 and also for all
four alternative Watson–Crick base pairings between
positions 1 and 12. These searches were done in stages,
as outlined below. An initial search revealed that the
Table 1. List of c-kit87 structures examined by molecular dynamics
simulations
Position 5 Position 9 Position 11 RMSD (A ˚ )
Native A(2) C(2) C(6) 1.6
Mutant 1: A5G G(0) C C 2
Mutant 2: A5C C(0) C C 1.8
Mutant 3: A5T T(59) C C 1.8
Mutant 4: C9G A G(36) C 1.8
Mutant 5: C9A A A(17) C 2.2
Mutant 6: C9T A T(6) C 1.6
Mutant 7: C11G A C G(42) 1.9
Mutant 8: C11A A C A(6) 2
Mutant 9: C11T A C T(7) 2.1
Mutant 10: AGTAG A C C 1.8
The numbers in parentheses are the frequency of occurrence of that
residue in a particular position, as found in this work. The right-hand
column lists the RMSD values arising from the simulations.
Nucleic Acids Research, 2007, Vol. 35, No. 17 5801native 22-mer c-kit87 sequence has only a single occur-
rence in the human genome.
There are 64 possible combinations for the three ’ﬂipped
out’ bases at the 5, 9 and 11 positions. A total of 61
sequence occurrences were found, corresponding to just
12 unique sequences (Figure 2a). The relative frequencies
with which diﬀerent bases occur are not random, with
sequences that have T, G and G substitutions at the 5, 9
and 11 positions being the most common type, of which
21 were found. The thymine substitution at the 5 position
Sequence Number
of hits
Substituted
bases 
AGGGTGGGGGGTGGGAGGAGGG  21  T G G 
AGGGTGGGAGGTGGGAGGAGGG  15  T A G 
AGGGTGGGGGTTGGGAGGAGGG  6  T G T 
AGGGTGGGTGGTGGGAGGAGGG  5  T T G 
AGGGTGGGGGATGGGAGGAGGG  4  T G A 
AGGGTGGGGGCTGGGAGGAGGG  4  T G C 
AGGGAGGGCGCTGGGAGGAGGG  1  A C C 
AGGGAGGGGGCTGGGAGGAGGG  1  A G C 
AGGGTGGGAGATGGGAGGAGGG  1  T A A 
AGGGTGGGAGTTGGGAGGAGGG  1  T A T 
AGGGTGGGCGGTGGGAGGAGGG  1  T C G 
AGGGTGGGTGATGGGAGGAGGG  1  T T A 
AGGGAGGGGGCTGGGAGCAGGG 1  A  G C C 
AGGGAGGGTGCTGGGAGTAGGG  1  A T C T 
AGGGCGGGGGGTGGGAGAAGGG 1  C  G G A 
AGGGTGGGAGATGGGAGTAGGG  1  T A A T 
AGGGTGGGGGTTGGGAGCAGGG 1  T  G  T  C 
AGGGTGGGAGGTGGGAGAAGGG  2  T A G A 
AGGGTGGGGGGTGGGAGAAGGG  2  T G G A 
    
TGGGTGGGGGGAGGGAGGAGGG  2  T G G G 
TGGGAGGGAGGAGGGAGCAGGG  1  A A G C 
TGGGAGGGAGGAGGGAGGAGGG  1  A A G G 
TGGGAGGGGGTAGGGAGCAGGG  1  A G T C 
TGGGAGGGTGCAGGGAGGAGGG  1  A T C G 
TGGGCGGGAGGAGGGAGGAGGG  1  C A G G 
TGGGGGGGCGGAGGGAGAAGGG  1  G C G A 
TGGGTGGGAGTAGGGAGCAGGG  1  T A T C 
TGGGTGGGGGTAGGGAGGAGGG  1  T G T G 
TGGGTGGGTGGAGGGAGGAGGG  1  T T G G 
GGGGAGGGGGCCGGGAGAAGGG  1  A G C A 
GGGGAGGGGGGCGGGAGGAGGG  1  A G G G 
GGGGGGGGTGGCGGGAGTAGGG  1  G T G T 
GGGGTGGGGGGCGGGAGGAGGG  3  T G G G 
CGGGAGGGGGAGGGGAGGAGGG  1  A G A G 
CGGGGGGGCGGGGGGAGCAGGG  1  G C G C 
CGGGGGGGGGAGGGGAGGAGGG  1  G G A G 
CGGGTGGGGGAGGGGAGTAGGG  1  T G A T 
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Figure 2. (a) Variations at the 5, 9 and 11 positions, Figure 2 (b) variations at the 5, 9, 11 and 18 positions (c) variants at the 5, 9, 11 and 18 position
when A1 and T12 are transposed to T1 and A12, (d) variants at the 5, 9, 11 and 18 positions with G1 and C12 and (e) variants at the 5, 9, 11 and
18 positions with C1 and G12.
5802 Nucleic Acids Research, 2007, Vol. 35, No. 17occurs in ca. 97% of the sequence hits and the 9 and
11 positions were most frequently guanines. Sequences
closely similar to the c-kit87 sequence itself are exception-
ally rare. Only one other sequence has an adenine at the
5 position, only one other sequence has a cytosine at the
9 position and of the ﬁve other sequences which have
a cytosine at the 11 position only one has another of
the substituted bases in common with the c-kit87 native
sequence.
Examination of substitutions at position 18 in addition
to those at the 5, 9 and 11 positions, showed that although
there are a further 192 possible sequence combinations,
only nine more actually occur (Figure 2b). Again none of
these nine additional sequences have more than two of the
substituted bases in common with the c-kit87 sequence,
and only two sequences have two bases in common, and
the remaining seven have none in common. Our previous
analysis of quadruplex loop occurrences in the human
genome (17) found that loops of sequence AGGA, and
therefore sequences containing AGGAG, are highly
over-represented. Out of the many thousands of loop
sequences which were found when searching for potential
quadruplex sequences, AGGA was the 14th most
frequently found loop.
Searches for alternative Watson–Crick base-pairing
combinations between the A1 and T12 positions yielded
only 21 further hits (from a possible 768 more sequences),
the majority of which have T at the 1st position and an
A at the 12th position (Figure 2c). Again there were no
other sequences which diﬀer from the native c-kit87 in
only the alternative 1–12 pairing, although one sequence
diﬀered in only the 1–12 pairing together with the
9 position. Figure 2d and e shows that the alternative
1–12 base pairings G-C and C-G have even fewer sequence
hits, with just six and four sequences found respectively.
Again these were dissimilar to the native c-kit87 sequence.
A search for occurrences of the mutated c-kit sequences
used in the initial study (26) (none of which form a
stable quadruplex structure), found no hits for two of
the sequences examined, (AGGGAGGGCGCTGGGCG
CTGGG and AGGGAGGGCGCTGGGCGGCGGG).
There are seven occurrences of the third sequence,
AGGGAGGGAGGAGGGAGGAGGG (Table 2) in
the human genome. Two instances of this high purine-
content sequence occurred in a potential promoter region,
two instances were close together within an intron, and the
other two were not near any regions of biological
importance as far as is known.
The distances to putative transcription start sites (TSS)
were then examined for all of these sequence variants
(Tables 3 and 4). The majority do not occur within genes,
but are distributed in non-coding regions. The c-kit87
native sequence, which is 34 bases upstream of the TSS,
is by far the closest to its TSS. The next closest is
ENSG00000185245 (coding for Platelet glycoprotein Ib
alpha chain precursor) which appears 147 bases upstream
of its transcription start site. The sequence which bears
the greatest similarity to the c-kit87 sequence, diﬀering
only by a C in the 9th position, occurs upstream of the
transcription start site of the gene ENSG00000136213
(coding for the protein carbohydrate sulfotransferase 12);
however this sequence is far upstream, at  18.6kb from
the TSS). The remaining sequences are also, in general,
located in quite remote positions.
We have also examined the phylogenetic features of the
c-kit87 sequence. Table 5 shows the results of the multiple
sequence alignment between the upstream sequences of
several c-kit87 orthologues. The two non-mammalian
sequences gave very dissimilar alignments to the rest of the
species, however the mammalian sequences were similar
enough to identify the relevant, orthologous upstream
regions. The opossum and macaque sequences were
identical to the human while the cow sequence diﬀered
by only one base, where a cytosine appears instead of
guanine at position 21. The mouse and rat sequences are
identical. However, they have an adenine inserted at the
2nd position and a deletion at 9 and 15 which seem to
make it impossible for them to form quadruplex structures
with the same topology as the human c-kit sequence. They
remain guanine-rich however, so it is not impossible that
they can fold into an alternative quadruplex topology.
As a check on the sequence occurrences we have
compared search results for diﬀerent G-rich sequences,
using the non-quadruplex-forming c-kit87 mutants 1m,
2m and 3m. In total there were 38 hits for sequence 1m,
none for sequence 2m and two for sequence 3m (Tables 6
and 7). One of the sequences appears 71 bases upstream of
ensembl gene ENSG00000133466 (HGNC name: C1q
tumor necrosis factor-related protein 6) and one occurs
228 bases upstream of the transcription start site of
ensembl gene ENSG00000185985 (HGNC name: SLIT
and NTRK-like family, member 2).
CD studies
The UV and CD spectra for the c-kit87 sequence and the
ten mutants are shown in Figure 3. All of the UV spectra
Table 2. Occurrences in the human genome of the non-quadruplex forming sequences examined by Rankin et al. (26)
1 AGGGAGGGAGGAGGGAGGAGGG In the middle of chromosome 3: nearest known gene is 82008 bases away
2 CCCTCCTCCCTCCTCCCTCCCT 2694 bases upstream of ENSG00000004866 (suppression of tumorigenicity 7)
3 CCCTCCTCCCTCCTCCCTCCCT Within the third intron of ENSG00000133195 (solute carrier family 39 (metal ion transporter,
member 11)
4 CCCTCCTCCCTCCTCCCTCCCT Within the third intron of ENSG00000133195 (solute carrier family 39 (metal ion transporter,
member 11)
5 CCCTCCTCCCTCCTCCCTCCCT 3143 bases upstream of ENSG00000183019 (function seems to be unknown)
6 CCCTCCTCCCTCCTCCCTCCCT 228 bases upstream of ENSG00000185985 SLIT and NTRK-like family, member 2
7 CCCTCCTCCCTCCTCCCTCCCT 210 bases upstream of ENSG00000185985 SLIT and NTRK-like family, member 2
Nucleic Acids Research, 2007, Vol. 35, No. 17 5803are identical. The CD spectra all show the same pattern of
minimum at 240nm and maximum at 262nm, although
there are signiﬁcant diﬀerences in peak heights.
Simulations
We have undertaken molecular dynamics simulations on
the native c-kit87 structure and ten mutants, as detailed
above and in Table 1. The root mean-square deviation
(RMSD) over the course of a molecular dynamics
simulation was used as a measure of the conformational
stability of a structure or model during that simulation.
The native c-kit87 NMR model and the mutant models
examined here are extremely stable structures, as is evident
from the stable and small RMSDs over the timescales
of 10ns simulations, starting from the initial structure.
The maximum variance ranged between 1.6 and 2.2A ˚ for
the native and mutant 5 respectively and is shown in
Table 1.
A more detailed picture of diﬀerences in residue
mobility within and between simulations was obtained
from graphs of the root mean-square ﬂuctuation (RMSF)
of residues relative to the average structure. The RMSF
proﬁles of all the mutants are somewhat similar to that
Table 3. Sequences which are upstream relative to known genes. Those with genes on either side are in the upstream regions of both genes
Gene ensembl ID Number of bases
from TSS
Sequence Number of bases
from TSS
Gene ensembl ID
AGGGAGGGCGCTGGGAGGAGGG 34 ENSG00000157404
ENSG00000205709 9359 AGGGTGGGAGATGGGAGTAGGG 147 ENSG00000185245
ENSG00000092148 401 CGGGAGGGGGAGGGGAGGAGGG 37043 ENSG00000202402
ENSG00000195330 1024 AGGGTGGGGGTTGGGAGGAGGG
ENSG00000195067 4844 AGGGTGGGGGTTGGGAGGAGGG 1051 ENSG00000194918
ENSG00000169892 1340 AGGGTGGGAGGTGGGAGGAGGG
ENSG00000109956 126892 AGGGAGGGGGCTGGGAGCAGGG 196763 ENSG00000204236
AGGGAGGGGGCTGGGAGGAGGG 18651 ENSG00000136213
ENSG00000190177 512336 AGGGCGGGGGGTGGGAGAAGGG
ENSG00000111716 77565 AGGGTGGGAGATGGGAGGAGGG
ENSG00000179862 87893 AGGGTGGGAGGTGGGAGAAGGG 29076 ENSG00000171793
AGGGTGGGAGGTGGGAGAAGGG 116715 ENSG00000166035
AGGGTGGGAGGTGGGAGGAGGG 54970 ENSG00000199297
ENSG00000193578 3626 AGGGTGGGAGGTGGGAGGAGGG
AGGGTGGGAGGTGGGAGGAGGG 51108 ENSG00000182824
ENSG00000128185 32965 AGGGTGGGAGGTGGGAGGAGGG
ENSG00000187979 50633 AGGGTGGGAGGTGGGAGGAGGG
ENSG00000181250 1371257 AGGGTGGGAGGTGGGAGGAGGG 372140 ENSG00000199778
ENSG00000190535 622126 AGGGTGGGAGGTGGGAGGAGGG
ENSG00000199652 615165 AGGGTGGGAGGTGGGAGGAGGG 747692 ENSG00000193275
ENSG00000193660 216206 AGGGTGGGAGGTGGGAGGAGGG
ENSG00000163492 155574 AGGGTGGGAGGTGGGAGGAGGG
ENSG00000113504 82344 AGGGTGGGCGGTGGGAGGAGGG 7270 ENSG00000174358
AGGGTGGGGGATGGGAGGAGGG 118987 ENSG00000205666
ENSG00000123243 22080 AGGGTGGGGGATGGGAGGAGGG 14218 ENSG00000151655
AGGGTGGGGGCTGGGAGGAGGG 144423 ENSG00000199222
AGGGTGGGGGGTGGGAGAAGGG 3151 ENSG00000187806
ENSG00000191596 21490 AGGGTGGGGGGTGGGAGAAGGG
ENSG00000136149 2368405 AGGGTGGGGGGTGGGAGGAGGG
ENSG00000177138 212606 AGGGTGGGGGGTGGGAGGAGGG 24604 ENSG00000194029
AGGGTGGGGGGTGGGAGGAGGG 236887 ENSG00000192765
ENSG00000185555 2200 AGGGTGGGGGGTGGGAGGAGGG
AGGGTGGGGGGTGGGAGGAGGG 219635 ENSG00000018236
ENSG00000197445 191931 AGGGTGGGGGGTGGGAGGAGGG
AGGGTGGGGGGTGGGAGGAGGG 22768 ENSG00000185744
ENSG00000189981 187334 AGGGTGGGGGGTGGGAGGAGGG
AGGGTGGGGGGTGGGAGGAGGG 455385 ENSG00000154478
AGGGTGGGGGGTGGGAGGAGGG 34226 ENSG00000154478
ENSG00000133424 734086 AGGGTGGGGGTTGGGAGCAGGG 411717 ENSG00000175329
AGGGTGGGGGTTGGGAGGAGGG 18610 ENSG00000100739
ENSG00000186964 5596 AGGGTGGGTGATGGGAGGAGGG
AGGGTGGGTGGTGGGAGGAGGG 199573 ENSG00000102290
ENSG00000201475 645873 AGGGTGGGTGGTGGGAGGAGGG 179263 ENSG00000099715
AGGGTGGGTGGTGGGAGGAGGG 58391 ENSG00000088538
AGGGTGGGTGGTGGGAGGAGGG 13880 ENSG00000193070
ENSG00000204966 127294 GGGGGGGGTGGCGGGAGTAGGG 120459 ENSG00000189221
ENSG00000196406 100265 GGGGTGGGGGGCGGGAGGAGGG 38941 ENSG00000165509
ENSG00000071564 103462 TGGGAGGGAGGAGGGAGGAGGG 19364 ENSG00000205922
ENSG00000192873 551362 TGGGTGGGGGGAGGGAGGAGGG 242860 ENSG00000200960
ENSG00000190169 169776 TGGGTGGGGGGAGGGAGGAGGG 1955948 ENSG00000202478
ENSG00000118487 471843 TGGGTGGGGGTAGGGAGGAGGG
5804 Nucleic Acids Research, 2007, Vol. 35, No. 17observed for the native structure. In particular, the peaks
in the RMSF proﬁle correspond to residues 5, 9 and 11
(Figure 4a). The NMR structure shows that these three
bases do not interact directly with any other part of the
structure and hence do not play any role in stabilizing it.
This is fully conﬁrmed by the simulation of the native
structure and of the 5, 9 and 11 mutants.
The guanine bases which contribute to quartet forma-
tion are extremely stable, whereas the AGGAG loop
(and nucleotide G18 in particular) shows signiﬁcant ﬂexi-
bility. Interestingly, as predicted by our bioinformatics
results, mutation of G18 to T18 results in the retention of
the same topology as the native sequence. This can be
explained by the overall ﬂexible nature of the AGGAG
loop, which would allow the G18T modiﬁcation to be
adopted into a similar folding topology. The G17–G18
stacking in the loop is similar to that found in the T4-T5
stacking adopted in the loop region of the crystal structure
of the Oxytricha telomeric sequence G4T4G4 (40: PDB
id 1JPQ).
Mutants 3 (A5T) and 6 (C9T) also exhibit patterns of
ﬂexibility that are very similar to the native structure
(Figure 4b). This is in accord with the NMR studies where
again these modiﬁcations produced a structure with same
topology as the native. However, modiﬁcation of C11 to
T11 was found to produce a mixture of structures with
A1–T12 base pairing (in the native structure) and A1–T11
base pairing (in the mutant). Examining the RMSF proﬁle
for the mutant-9 (C11T) simulation (Figure 4c), we see
Table 4. Description of highlighted genes in Table 3
Ensembl ID Description
ENSG00000185245 (GP1BA) glycoprotein Ib (platelet)
alpha polypeptide
ENSG00000092148 (HECTD1) HECT domain containing 1
ENSG00000195330 tRNA pseudogene
ENSG00000194918 tRNA pseudogene
ENSG00000169892 CDNA FLJ46366 ﬁs, clone TESTI4051388
Table 5. Multiple sequence alignment of the human c-kit87 and surrounding region with orthologous regions from various species
HUMAN TGGCCGGCGCG-CAGAGGGAGGGCGCTGGGAGGAGGGGCTGCT-------GCTCGCC-
MACAQUE TGGCCGGCGCG-CAGAGGGAGGGCGCTGGGAGGAGGGGCTGCT-------GCTCGGC-
MOUSE TGGCCA-CGAG-CTGGGAGGAGG-GCTGG-AGGAGGGGCTGTC-------GCGCGCC-
RAT TGGCCA-CGCG-CTGGGAGGAGG-GCTGG-AGGAGGGGCTGTC-------GCGCGCC-
COW TGGCCGCCGCT-CAGGGGGAGGGCGCTGGGAGGAGCGGCCGCG-------GCTTGGC-
OPOSSUM TGGCCGGCGTGGCAAGGGGAGGGCGCTGGGAGGAGGGGCTGCTCTCCTTTGCTAGCCT
CHICKEN GGCCGGCAGTACTCCGC-AGCCTCCCGCG--GGGTTCGGGCATATATGCGCGCCGGGT
ZEBRAFISH TGTTGATGTTGTTACCTCCCTGTCCCCGCCCAGGCTCGCTCGTCGTTC--CGCATGAC
Table 6. Variants of non-quadruplex forming sequence 1m which occur upstream of known genes
Gene ensembl ID
<------- |
Number of bases
from TSS
Sequence Number of bases
from TSS
Gene ensembl ID
|--------->
ENSG00000004866 2694 AGGGAGGGAGGAGGGAGGAGGG 6219 ENSG00000195520
ENSG00000199778 125965 AGGGTGGGGGGAGGGAGCAGGG 483712 ENSG00000181250
ENSG00000162825 2997 AGGGTGGGGGGAGGGAGGAGGG
ENSG00000120370 161143 AGGGTGGGGGGAGGGAGGAGGG
ENSG00000199285 179234 AGGGTGGGGGTAGGGAGGAGGG 552024 ENSG00000176435
AGGGAGGGTGGAGGGAGAAGGG 127190 ENSG00000176769
ENSG00000205866 1042 AGGGAGGGGGGAGGGAGGAGGG
ENSG00000205864 10129 AGGGAGGGGGGAGGGAGGAGGG 1886 ENSG00000205865
AGGGAGGGAGCAGGGAGGAGGG 71 ENSG00000133466
ENSG00000144810 403994 AGGGTGGGAGGAGGGAGAAGGG
ENSG00000185985 228 AGGGAGGGAGGAGGGAGGAGGGA
GGGAGGAGGGAGGAGGG
ENSG00000183019 3143 AGGGAGGGAGGAGGGAGGAGGG
ENSG00000176783 37266 AGGGAGGGGGGAGGGAGGAGGG 21147 ENSG00000202120
Table 7. Variants of non-quadruplex forming sequence 3m which occur upstream of known genes
Gene ensembl ID
<------- |
Number of bases
from TSS
Sequence Number of bases
from TSS
Gene ensembl ID
|--------->
ENSG00000160145 61150 AGGGCGGGCGTTGGGCGGCGGG 53107 ENSG00000065371
ENSG00000202265 28176 AGGGTGGGGGCTGGGCGGCGGG 134617 ENSG00000195069
Nucleic Acids Research, 2007, Vol. 35, No. 17 5805that residue A1 has increased ﬂexibility compared to the
ﬂexibility of residue A1 in the native structure simulation.
Furthermore, the ﬂexibility of residue C9 in mutant 9 is
considerably reduced. A slight increase in ﬂexibility of
residue T12 is also observed, suggesting that some minor
structural changes may have occurred during the course of
the simulations. To investigate the dominant motions,
principal components analysis was performed. By calcu-
lating the eigenvectors from the covariance matrix of a
simulation and then ﬁltering the trajectories along each of
the diﬀerent eigenvectors, it is possible to identify the
dominant motions observed during a simulation, by visual
inspection. Plotting the start and the end points of eigen-
vectors as arrows, highlights the direction of motion for
a particular atom. Application of such an analysis to these
simulations enabled us to identify the structural changes
occurring between A1–T2 and T11. In order for the
A1–T11 base pair to form, the A1–T12 base pair needs to
be broken and T12 has to move out and pave the way for
T11 to occupy its place (Figure 5). This is clearly observed
in the PCA analysis; however the timescale of the
simulations are too short for these entire processes to be
fully simulated.
CONCLUSIONS
The 22-nt c-kit87 promoter sequence is unique within the
human genome. Its fold and tertiary structure does not
have precedent among known DNA quadruplexes. The
present theoretical and experimental studies have shown
that (i) none of the closely related sequences (encom-
passing all nucleotides not involved in the maintenance of
structural integrity) occur immediately upstream (<100nt)
of a transcription start site, and (ii) that all of these
sequences correspond to the same stable tertiary structure.
The identity of the CD spectral maxima and minima
indicate that all the ten related mutant sequences adopt
the same overall fold as the native c-kit87 sequence; the
diﬀerences in peak height can be ascribed to the sequence
diﬀerences, although a detailed analysis is beyond the
scope of this article. It is concluded that the c-kit87
tertiary structure may also be formed in a small number
of other loci in the human genome, but the likelihood of
these playing a signiﬁcant role in the expression of
particular genes is small. The c-kit87 quadruplex thus
fulﬁls a fundamental criterion of a ‘good’ drug target, of
possessing distinctive 3D structural features that are only
present in at most a handful of other genes, with only one,
that for platelet glycoprotein Ib alpha chain precursor
(ENSG00000185245) also being in a likely core promoter
region. The genome searches with mutant c-kit87
sequences that are known not to form quadruplexes,
found a number of hits; two are close to transcription start
sites, demonstrating the importance of knowledge of the
folding behaviour.
DNA is normally considered as a structurally homo-
geneous molecule, deﬁned in its ﬂexibility by the
constraints of the double helix. The possibility of DNA
forming higher order structures is not new, and triplexes
and quadruplexes have long been postulated, especially in
regulatory sequences. However, until now even these
features have not been considered to possess a high degree
of complexity and variation (though the structures of the
c-myc quadruplexes do show features that are absent in
previous quadruplex structures). The c-kit87 structure,
involving 18 out of 22nt in tertiary interactions, shows
that non-duplex DNA sequences can adopt highly stable
and complex arrangements. We are as yet far from
knowing the rules governing these folds or the extent to
which they may occur.
Searches for potential quadruplex sequences in non-
telomeric DNAs have always used a template pattern
based on known quadruplex sequences and their topolo-
gies (17,20,41,42), in which four runs of guanine bases are
separated by three distinct loop regions: Gm Xn Gm Xo Gm
Xp Gm where m=3–5 and n,o,p=1–7. In lieu of
structural data providing evidence that additional
sequence patterns are valid, we suggest that this remains
a reasonable assumption. Important caveats are (i) that a
particular topology cannot be assumed purely on the basis
of the sequence alone, and (ii) that the occurrence of
200 220 240 260 280 300 320 340
−4
−2
0
2
4
6
8
10
12
0.0
0.5
1.0
1.5
2.0
A
b
s
o
r
b
a
n
c
e
 A5G
 A5C
 A5T
 C9G
 C9A
 C9T
 C11G
 C11A
 C11T
 G18T
 Native
[
θ
]
 
×
 
1
0
5
 
(
d
e
g
 
c
m
2
 
d
m
o
l
−
1
)
Wavelength (nm)
Figure 3. UV and CD spectra of the c-kit87 native sequence and
the ten mutant sequences, taken in 50mMKCl solution with a 1cm
path-length cell.
5806 Nucleic Acids Research, 2007, Vol. 35, No. 17a sequence per se does not necessarily mean that it corres-
ponds to a stable or potentially stable quadruplex—as is
the case with a number of the c-kit87 mutants (26). The
distinctly non-random distribution of particular bases at
the non-essential 5, 9, 11 and 18 positions of the c-kit87
sequence is a surprising observation, which is being
further examined experimentally and theoretically.
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